Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the problem of conjunction and phasing-Reference-Cited by-同舟云学术

Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the problem of conjunction and phasing

Published:2021-10-22 Issue:3 Volume:18 Page:313-319
ISSN:2306-5524
Container-title:Obesity and metabolism
language:
Short-container-title:Obes. metabol.

Author:

Kiseleva E. V.¹^ORCID,Demidova T. Y.¹

Affiliation:

1. Pirogov Russian National Research Medical University (RNRMU)

Publisher

Endocrinology Research Centre

Subject

Public Health, Environmental and Occupational Health,Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference57 articles.

1. В Who.int [Internet]. The top 10 causes of death [cited 2020 9 Dec]. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death

2. Rothberg GE, ed. Metabolic syndrome. Moscow: MED-M54 press-inform; 2007. (In Russ.).

3. Lang GF. Hypertonic disease. Leningrad: Medgiz; 1950. (In Russ.).

4. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-1607. doi: https://doi.org/10.2337/diab.37.12.1595

5. D’Adamo E, Marcovecchio ML, Giannini C, et al. The possible role of liver steatosis in defining metabolic syndrome in prepubertal children. Metabolism. 2010;59:671-676. doi: https://doi.org/10.1016/j.metabol.2009.09.012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of surgical treatment of obesity on the course of nonalcoholic fatty liver disease;Obesity and metabolism;2023-07-27

2. Type 2 diabetes mellitus, non-alcoholic fatty liver disease and cardiovascular disease: causal relationships and the role of anti-diabetic drugs;FOCUS. Endocrinology;2023-05-10

3. Non-alcoholic fatty liver disease and type 2 diabetes mellitus: general approaches to the choice of therapy;Terapevticheskii arkhiv;2022-11-22

4. The FINDRISC scale as a risk assessment tool for liver fibrosis in patients with nonalcoholic fatty liver disease;Obesity and metabolism;2022-08-28